SSI Strategy
SSI Strategy provides a comprehensive range of services for the biotech and pharmaceutical industries, including Clinical Operations, Medical Affairs, and Digital-Led Biotech Strategy, supported by a global presence and a dedicated Executive Advisory Network.
Services
SSI Strategy offers a variety of specialized services tailored to the biotech and pharmaceutical industries. These services include Clinical Operations, Clinical Development, Evidence Generation, Safety & Pharmacovigilance, Medical Affairs, and Digital-Led Biotech Strategy. They also provide a Strategic Medical Office service designed to help biotech companies create compelling medical stories and achieve significant regulatory and funding milestones.
Executive Advisory Network
SSI Strategy has established a dedicated Executive Advisory Network that includes globally recognized experts in the pharmaceutical and biotech industries. This network provides clients with access to thought leaders who offer strategic insights and guidance, ensuring that clients can leverage top-tier expertise in navigating complex industry challenges.
Health Economics and Outcomes Research (HEOR) and Real-World Evidence (RWE)
SSI Strategy supports clients with Health Economics and Outcomes Research (HEOR) and Real-World Evidence (RWE) services. These services are designed to ensure effective evidence generation and value demonstration, helping clients substantiate their products' economic value and clinical effectiveness in real-world settings.
Global Presence
SSI Strategy operates on a global scale, with teams located in several major cities including San Francisco, Chicago, New York, Boston, New Jersey, and London. This extensive geographical footprint allows SSI Strategy to provide localized expertise and support to clients around the world, enhancing their ability to meet diverse regulatory requirements and market needs.
Interim Leadership Services
SSI Strategy offers interim leadership services to fill critical roles within client organizations. These include positions such as Chief Medical Officer (CMO) and VP Clinical Development. By providing experienced interim leaders, SSI Strategy ensures that clients maintain continuity in their operations and strategic initiatives during transitions.
Digital Transformation
SSI Strategy has expertise in digital transformation specifically for pharmacovigilance and clinical operations. They help clients automate processes and improve compliance through digital innovations, ensuring that companies stay ahead in an increasingly digital and regulatory-driven environment.
Podcast: The Emerging Biotech Leader
SSI Strategy produces a podcast called 'The Emerging Biotech Leader,' which discusses various topics pertinent to the biotech and pharmaceutical industries. The podcast provides insights and discussions from industry experts, covering trends, challenges, and opportunities in the field.
Mergers and Partnerships
SSI Strategy has been involved in significant mergers and partnerships to enhance its service offerings and market reach. Noteworthy collaborations include the merger with NDA Group and the partnership with Medocity. These strategic moves allow SSI Strategy to leverage complementary strengths and provide enhanced value to clients.